Top

Molecular Cancer

Published in:

Open Access 01-12-2010 | Research

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

Published in: Molecular Cancer | Issue 1/2010

Title: Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
Publication date: 01-12-2010
Published in: Molecular Cancer / Issue 1/2010
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/1476-4598-9-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2010

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

Glycogen synthase kinase 3 beta: can it be a target for oral cancer

Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition

Keynote webinar | Spotlight on antibody–drug conjugates in cancer